Repligen Q2 Adjusted EPS $0.53 Beats $0.49 Estimate, Sales $159.20M Miss $167.15M Estimate
Portfolio Pulse from Benzinga Newsdesk
Repligen (NASDAQ:RGEN) reported Q2 earnings of $0.53 per share, beating the analyst consensus estimate of $0.49 by 8.16%. However, this is a 41.76% decrease from the same period last year. The company's quarterly sales of $159.20 million missed the analyst consensus estimate of $167.15 million by 4.76%, marking a 23.33% decrease from last year.
August 04, 2023 | 11:01 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Repligen's Q2 earnings beat estimates but are significantly down YoY. Sales also missed estimates and are down YoY.
Repligen's earnings beat estimates, which is positive. However, the significant YoY decrease in both earnings and sales is a negative signal, which could lead to a decrease in the stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100